The expression levels of CD4+, a T cell marker, and CD68+, a macrophage marker, were significantly higher in the COVID-19 group than in control samples, suggesting that T lymphocytes and macrophages drive the pathological changes associated with SARS-CoV-2 infection. The gene discussed is CD68; the disease is COVID-19.